Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: A population-based study

{ 'indexed': {'date-parts': [[2023, 4, 27]], 'date-time': '2023-04-27T04:47:05Z', 'timestamp': 1682570825909}, 'reference-count': 72, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2023, 6, 1]], 'date-time': '2023-06-01T00:00:00Z', 'timestamp': 1685577600000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2023, 4, 2]], 'date-time': '2023-04-02T00:00:00Z', 'timestamp': 1680393600000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by/4.0/'}], 'funder': [ { 'DOI': '10.13039/501100008530', 'name': 'European Regional Development Fund', 'doi-asserted-by': 'publisher'}, { 'DOI': '10.13039/501100004587', 'name': 'Instituto de Salud Carlos III', 'doi-asserted-by': 'publisher'}], 'content-domain': { 'domain': [ 'clinicalkey.fr', 'clinicalkey.jp', 'clinicalkey.es', 'clinicalkey.com.au', 'clinicalkey.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2023, 6]]}, 'DOI': '10.1016/j.euroneuro.2023.03.011', 'type': 'journal-article', 'created': {'date-parts': [[2023, 4, 4]], 'date-time': '2023-04-04T07:35:03Z', 'timestamp': 1680593703000}, 'page': '96-108', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: A population-based ' 'study', 'prefix': '10.1016', 'volume': '71', 'author': [ { 'ORCID': 'http://orcid.org/0000-0001-6466-6213', 'authenticated-orcid': False, 'given': 'Irene', 'family': 'Visos-Varela', 'sequence': 'first', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-0648-7716', 'authenticated-orcid': False, 'given': 'Maruxa', 'family': 'Zapata-Cachafeiro', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-3655-100X', 'authenticated-orcid': False, 'given': 'María', 'family': 'Piñeiro-Lamas', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Eduardo', 'family': 'Carracedo-Martínez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marc', 'family': 'Saez', 'sequence': 'additional', 'affiliation': []}, {'given': 'María Teresa', 'family': 'Herdeiro', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adolfo', 'family': 'Figueiras', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ángel', 'family': 'Salgado-Barreira', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.euroneuro.2023.03.011_bib0001', 'doi-asserted-by': 'crossref', 'first-page': '1705', 'DOI': '10.1016/S0140-6736(20)31030-8', 'article-title': 'Use of renin–angiotensin–aldosterone system inhibitors and risk of ' 'COVID-19 requiring admission to hospital: a case-population study', 'volume': '395', 'author': 'Abajo', 'year': '2020', 'journal-title': 'Lancet'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0002', 'series-title': 'New Use of the SSRI Fluvoxamine in the Treatment of COVID-19 Symptoms', 'author': 'Alsabhan', 'year': '2022'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0003', 'doi-asserted-by': 'crossref', 'first-page': '458', 'DOI': '10.3389/fpsyt.2019.00458', 'article-title': 'Low-grade inflammation as a predictor of antidepressant and ' 'anti-inflammatory therapy response in MDD patients: a systematic review ' 'of the literature in combination with an analysis of experimental data ' 'collected in the EU-MOODINFLAME consortium', 'volume': '10', 'author': 'Arteaga-Henríquez', 'year': '2019', 'journal-title': 'Front. Psychiatry'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0004', 'doi-asserted-by': 'crossref', 'first-page': '925', 'DOI': '10.1097/PSY.0b013e3181f883ce', 'article-title': 'Selective serotonin reuptake inhibitor suppression of HIV infectivity ' 'and replication', 'volume': '72', 'author': 'Benton', 'year': '2010', 'journal-title': 'Psychosom. Med.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0005', 'doi-asserted-by': 'crossref', 'DOI': '10.2807/1560-7917.ES.2021.26.50.2101147', 'article-title': 'Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November ' 'to December 2021', 'volume': '26', 'author': 'Brandal', 'year': '2021', 'journal-title': 'Euro. Surveill.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0006', 'series-title': 'Applied Mixed Models in Medicine', 'author': 'Brown', 'year': '2006'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0007', 'doi-asserted-by': 'crossref', 'first-page': '177', 'DOI': '10.1038/d41586-021-00031-0', 'article-title': 'Could new COVID variants undermine vaccines? Labs scramble to find out', 'volume': '589', 'author': 'Callaway', 'year': '2021', 'journal-title': 'Nature'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0008', 'doi-asserted-by': 'crossref', 'first-page': '15', 'DOI': '10.1038/d41586-021-00241-6', 'article-title': 'How to redesign COVID vaccines so they protect against variants', 'volume': '590', 'author': 'Callaway', 'year': '2021', 'journal-title': 'Nature'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0009', 'doi-asserted-by': 'crossref', 'first-page': '2065', 'DOI': '10.1111/bcp.15126', 'article-title': 'Safety and efficacy of fluvoxamine in COVID-19 ICU patients: an open ' 'label, prospective cohort trial with matched controls', 'volume': '88', 'author': 'Calusic', 'year': '2022', 'journal-title': 'Br. J. Clin. Pharmacol.'}, { 'issue': '8', 'key': '10.1016/j.euroneuro.2023.03.011_bib0010', 'article-title': 'Pharmacological inhibition of acid sphingomyelinase prevents uptake of ' 'SARS-CoV-2 by epithelial cells', 'volume': '1', 'author': 'Carpinteiro', 'year': '2020', 'journal-title': 'Cell. Rep. Med.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0011', 'doi-asserted-by': 'crossref', 'first-page': '1501', 'DOI': '10.1001/jama.2021.4367', 'article-title': 'CDC interim recommendations for fully vaccinated people: an important ' 'first step', 'volume': '325', 'author': 'Christie', 'year': '2021', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0012', 'article-title': 'Efficacy and safety of selective serotonin reuptake inhibitors in ' 'COVID-19 management: a systematic review and meta-analysis', 'author': 'Deng', 'year': '2023', 'journal-title': 'Clin. Microbiol. Infect.'}, { 'issue': 'Suppl 3(S3)', 'key': '10.1016/j.euroneuro.2023.03.011_bib0013', 'doi-asserted-by': 'crossref', 'first-page': 'S185', 'DOI': '10.1002/hup.470100907', 'article-title': 'Comparative safety and tolerability of selective serotonin reuptake ' 'inhibitors', 'volume': '10', 'author': 'Devane', 'year': '1995', 'journal-title': 'Hum. Psychopharmacol.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0014', 'doi-asserted-by': 'crossref', 'first-page': '7', 'DOI': '10.1016/j.pbb.2016.02.005', 'article-title': 'Effects of escitalopram, R-citalopram, and reboxetine on serum levels ' 'of tumor necrosis factor-α, interleukin-10, and depression-like ' 'behavior in mice after lipopolysaccharide administration', 'volume': '144', 'author': 'Dong', 'year': '2016', 'journal-title': 'Pharmacol. Biochem. Behav.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0073', 'doi-asserted-by': 'crossref', 'first-page': '30', 'DOI': '10.1016/j.euroneuro.2022.10.004', 'article-title': 'Psychotropic drug repurposing for COVID-19: A systematic review and ' 'meta-analysis', 'volume': '66', 'author': 'Fico', 'year': '2023', 'journal-title': 'Eur. Neuropsychopharmacol.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0016', 'article-title': 'Antidepressant and antipsychotic drugs reduce viral infection by ' 'SARS-CoV-2 and fluoxetine shows antiviral activity against the novel ' 'variants in vitro', 'volume': '12', 'author': 'Fred', 'year': '2021', 'journal-title': 'Front. Pharmacol.'}, { 'issue': '1', 'key': '10.1016/j.euroneuro.2023.03.011_bib0017', 'doi-asserted-by': 'crossref', 'first-page': '341', 'DOI': '10.1038/s41398-022-02109-3', 'article-title': 'Association between antidepressant use and ED or hospital visits in ' 'outpatients with SARS-CoV-2', 'volume': '12', 'author': 'Fritz', 'year': '2022', 'journal-title': 'Transl. Psychiatry'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0018', 'doi-asserted-by': 'crossref', 'first-page': '33', 'DOI': '10.1016/j.biopsych.2015.11.003', 'article-title': 'The selective serotonin reuptake inhibitor citalopram decreases human ' 'immunodeficiency virus receptor and coreceptor expression in immune ' 'cells', 'volume': '80', 'author': 'Greeson', 'year': '2016', 'journal-title': 'Biol. Psychiatry'}, { 'issue': '2', 'key': '10.1016/j.euroneuro.2023.03.011_bib0019', 'doi-asserted-by': 'crossref', 'first-page': '249', 'DOI': '10.1007/s00406-020-01231-x', 'article-title': 'Repurposing of CNS drugs to treat COVID-19 infection: targeting the ' 'sigma-1 receptor', 'volume': '271', 'author': 'Hashimoto', 'year': '2021', 'journal-title': 'Eur. Arch. Psychiatry Clin. Neurosci.'}, { 'issue': '4', 'key': '10.1016/j.euroneuro.2023.03.011_bib0020', 'doi-asserted-by': 'crossref', 'first-page': '1898', 'DOI': '10.1038/s41380-021-01432-3', 'article-title': 'Mechanisms of action of fluvoxamine for COVID-19: a historical review', 'volume': '27', 'author': 'Hashimoto', 'year': '2022', 'journal-title': 'Mol. Psychiatry'}, { 'issue': '2', 'key': '10.1016/j.euroneuro.2023.03.011_bib0021', 'doi-asserted-by': 'crossref', 'first-page': '275', 'DOI': '10.1093/schbul/sbac118', 'article-title': 'Heightened COVID-19 mortality in people with severe mental illness ' 'persists after vaccination: a cohort study of greater manchester ' 'residents', 'volume': '49', 'author': 'Hassan', 'year': '2023', 'journal-title': 'Schizophr. Bull.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0022', 'doi-asserted-by': 'crossref', 'first-page': '5199', 'DOI': '10.1038/s41380-021-01021-4', 'article-title': 'Association between antidepressant use and reduced risk of intubation ' 'or death in hospitalized patients with COVID-19: results from an ' 'observational study', 'volume': '26', 'author': 'Hoertel', 'year': '2021', 'journal-title': 'Mol. Psychiatry'}, { 'issue': '12', 'key': '10.1016/j.euroneuro.2023.03.011_bib0023', 'doi-asserted-by': 'crossref', 'first-page': '7098', 'DOI': '10.1038/s41380-021-01254-3', 'article-title': 'Repurposing antidepressants inhibiting the sphingomyelinase ' 'acid/ceramide system against COVID-19: current evidence and potential ' 'mechanisms', 'volume': '26', 'author': 'Hoertel', 'year': '2021', 'journal-title': 'Mol. Psychiatry'}, { 'issue': '1', 'key': '10.1016/j.euroneuro.2023.03.011_bib0024', 'doi-asserted-by': 'crossref', 'first-page': '90', 'DOI': '10.1038/s41398-022-01804-5', 'article-title': 'Association between FIASMA psychotropic medications and reduced risk of ' 'intubation or death in individuals with psychiatric disorders ' 'hospitalized for severe COVID-19: an observational multicenter study', 'volume': '12', 'author': 'Hoertel', 'year': '2022', 'journal-title': 'Transl. Psychiatry'}, { 'issue': '19', 'key': '10.1016/j.euroneuro.2023.03.011_bib0025', 'doi-asserted-by': 'crossref', 'first-page': '5882', 'DOI': '10.3390/jcm11195882', 'article-title': 'Antidepressant use and its association with 28-day mortality in ' 'inpatients with SARS-CoV-2: support for the FIASMA model against ' 'COVID-19', 'volume': '11', 'author': 'Hoertel', 'year': '2022', 'journal-title': 'J. Clin. Med.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0026', 'doi-asserted-by': 'crossref', 'first-page': 'e18', 'DOI': '10.1017/S2045796021000743', 'article-title': 'Association between benzodiazepine receptor agonist use and mortality ' 'in patients hospitalised for COVID-19: a multicentre observational ' 'study', 'volume': '31', 'author': 'Hoertel', 'year': '2022', 'journal-title': 'Epidemiol. Psychiatr. Sci.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0027', 'doi-asserted-by': 'crossref', 'first-page': '1030', 'DOI': '10.1186/1471-2458-13-1030', 'article-title': 'Identifying patients with chronic conditions using pharmacy data in ' 'Switzerland: an updated mapping approach to the classification of ' 'medications', 'volume': '13', 'author': 'Huber', 'year': '2013', 'journal-title': 'BMC Public Health'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0028', 'doi-asserted-by': 'crossref', 'first-page': '5795', 'DOI': '10.3390/molecules26195795', 'article-title': 'Discovery, development, and patent trends on molnupiravir: a ' 'prospective oral treatment for COVID-19', 'volume': '26', 'author': 'Imran', 'year': '2021', 'journal-title': 'Molecules'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0029', 'doi-asserted-by': 'crossref', 'first-page': '64', 'DOI': '10.3390/vaccines10010064', 'article-title': 'Large-scale study of antibody titer decay following BNT162b2 mRNA ' 'vaccine or SARS-CoV-2 infection', 'volume': '10', 'author': 'Israel', 'year': '2021', 'journal-title': 'Vaccines (Basel)'}, { 'issue': '1', 'key': '10.1016/j.euroneuro.2023.03.011_bib0030', 'doi-asserted-by': 'crossref', 'first-page': '307', 'DOI': '10.1038/s41380-021-01309-5', 'article-title': 'The acid sphingomyelinase/ceramide system in COVID-19', 'volume': '27', 'author': 'Kornhuber', 'year': '2022', 'journal-title': 'Mol. Psychiatry'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0031', 'series-title': 'Sphingolipid Biosynthesis Inhibition as a Host Strategy Against Diverse ' 'Pathogens', 'author': 'Kumar', 'year': '2020'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0032', 'doi-asserted-by': 'crossref', 'first-page': '12920', 'DOI': '10.1038/s41598-022-17082-6', 'article-title': 'Robust antiviral activity of commonly prescribed antidepressants ' 'against emerging coronaviruses: in vitro and in silico drug repurposing ' 'studies', 'volume': '12', 'author': 'Kutkat', 'year': '2022', 'journal-title': 'Sci. Rep.'}, { 'issue': '4', 'key': '10.1016/j.euroneuro.2023.03.011_bib0033', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.dhjo.2022.101376', 'article-title': 'COVID-19 mortality burden and comorbidity patterns among decedents with ' 'and without intellectual and developmental disability in the US', 'volume': '15', 'author': 'Landes', 'year': '2022', 'journal-title': 'Disabil. Health J.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0034', 'doi-asserted-by': 'crossref', 'DOI': '10.1155/2015/217047', 'article-title': 'Medication adherence measures: an overview', 'volume': '2015', 'author': 'Lam', 'year': '2015', 'journal-title': 'Biomed Res. Int.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0035', 'doi-asserted-by': 'crossref', 'first-page': '2292', 'DOI': '10.1001/jama.2020.22760', 'article-title': 'Fluvoxamine vs placebo and clinical deterioration in outpatients with ' 'symptomatic COVID-19: a randomized clinical trial', 'volume': '324', 'author': 'Lenze', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0036', 'doi-asserted-by': 'crossref', 'first-page': '120', 'DOI': '10.1007/s11481-006-9054-y', 'article-title': 'The role of cohort studies in drug development: clinical evidence of ' 'antiviral activity of serotonin reuptake inhibitors and HMG-CoA ' 'reductase inhibitors in the central nervous system', 'volume': '2', 'author': 'Letendre', 'year': '2007', 'journal-title': 'J. Neuroimmune Pharmacol.'}, { 'issue': '4', 'key': '10.1016/j.euroneuro.2023.03.011_bib0037', 'doi-asserted-by': 'crossref', 'first-page': '1775', 'DOI': '10.3233/JAD-201016', 'article-title': 'The impact of dementia on the clinical outcome of COVID-19: a ' 'systematic review and meta-analysis', 'volume': '78', 'author': 'Liu', 'year': '2020', 'journal-title': 'J. Alzheimers Dis.'}, { 'issue': '11', 'key': '10.1016/j.euroneuro.2023.03.011_bib0038', 'doi-asserted-by': 'crossref', 'first-page': '1259', 'DOI': '10.1016/j.jiph.2022.10.010', 'article-title': 'Effect of fluvoxamine on outcomes of nonhospitalized patients with ' 'COVID-19: a systematic review and meta-analysis', 'volume': '15', 'author': 'Lu', 'year': '2022', 'journal-title': 'J. Infect. Public Health'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0039', 'doi-asserted-by': 'crossref', 'first-page': '143', 'DOI': '10.1136/postgradmedj-2020-138903', 'article-title': 'Will vaccination refusal prolong the war on SARS-CoV-2?', 'volume': '97', 'author': 'Marcec', 'year': '2021', 'journal-title': 'Postgrad. Med. J.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0040', 'doi-asserted-by': 'crossref', 'first-page': '325', 'DOI': '10.1002/npr2.12194', 'article-title': 'SSRIs: applications in inflammatory lung disease and implications for ' 'COVID-19', 'volume': '41', 'author': 'Meikle', 'year': '2021', 'journal-title': 'Neuropsychopharmacol. Rep.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0041', 'doi-asserted-by': 'crossref', 'first-page': '1618', 'DOI': '10.1016/S0140-6736(22)00327-0', 'article-title': 'Symptom prevalence, duration, and risk of hospital admission in ' 'individuals infected with SARS-CoV-2 during periods of omicron and ' 'delta variant dominance: a prospective observational study from the ZOE ' 'COVID Study', 'volume': '399', 'author': 'Menni', 'year': '2022', 'journal-title': 'Lancet'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0042', 'series-title': 'The Effect of Antidepressants on Severity of COVID-19 in Hospitalized ' 'Patients: A Systematic Review and Meta-Analysis', 'author': 'Nakhaee', 'year': '2022'}, { 'issue': '4', 'key': '10.1016/j.euroneuro.2023.03.011_bib0043', 'doi-asserted-by': 'crossref', 'first-page': '853', 'DOI': '10.1016/j.pbb.2012.12.003', 'article-title': 'Effects of antidepressants on alternations in serum cytokines and ' 'depressive-like behavior in mice after lipopolysaccharide ' 'administration', 'volume': '103', 'author': 'Ohgi', 'year': '2013', 'journal-title': 'Pharmacol. Biochem. Behav.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0044', 'doi-asserted-by': 'crossref', 'first-page': '163', 'DOI': '10.1016/j.jocn.2021.03.010', 'article-title': 'Drug repurposing of selective serotonin reuptake inhibitors: could ' 'these drugs help fight COVID-19 and save lives?', 'volume': '88', 'author': 'Pashaei', 'year': '2021', 'journal-title': 'J. Clin. Neurosci.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0045', 'series-title': 'Mixed-Effects Models in S and S-PLUS', 'author': 'Pinheiro', 'year': '2000'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0046', 'doi-asserted-by': 'crossref', 'first-page': '276', 'DOI': '10.1038/s41586-021-03777-9', 'article-title': 'Reduced sensitivity of SARS-CoV-2 variant Delta to antibody ' 'neutralization', 'volume': '596', 'author': 'Planas', 'year': '2021', 'journal-title': 'Nature'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0047', 'doi-asserted-by': 'crossref', 'first-page': '4064', 'DOI': '10.1016/j.vaccine.2017.06.003', 'article-title': 'The complexity and cost of vaccine manufacturing—an overview', 'volume': '35', 'author': 'Plotkin', 'year': '2017', 'journal-title': 'Vaccine'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0048', 'doi-asserted-by': 'crossref', 'first-page': '9', 'DOI': '10.1016/j.crstbi.2020.12.001', 'article-title': 'Dual targeting of 3CLpro and PLpro of SARS-CoV-2: a novel ' 'structure-based design approach to treat COVID-19', 'volume': '3', 'author': 'Rajpoot', 'year': '2021', 'journal-title': 'Curr. Res. Struct. Biol.'}, { 'issue': '1', 'key': '10.1016/j.euroneuro.2023.03.011_bib0049', 'doi-asserted-by': 'crossref', 'first-page': '70', 'DOI': '10.3390/jcm11010070', 'article-title': 'Ongoing use of SSRIs does not alter outcome in hospitalized COVID-19 ' 'patients: a retrospective analysis', 'volume': '11', 'author': 'Rauchman', 'year': '2021', 'journal-title': 'J. Clin. Med.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0050', 'doi-asserted-by': 'crossref', 'first-page': '42', 'DOI': '10.1016/S2214-109X(21)00448-4', 'article-title': 'Effect of early treatment with fluvoxamine on risk of emergency care ' 'and hospitalisation among patients with COVID-19: the TOGETHER ' 'randomised, platform clinical trial', 'volume': '10', 'author': 'Reis', 'year': '2022', 'journal-title': 'Lancet Global Health'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0051', 'doi-asserted-by': 'crossref', 'first-page': '2389', 'DOI': '10.1001/jama.2022.9655', 'article-title': 'COVID-19 in 2022—the beginning of the end or the end of the beginning?', 'volume': '327', 'author': 'del Rio', 'year': '2022', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0052', 'first-page': '1', 'article-title': 'Why match? Investigating matched case-control study designs with causal ' 'effect estimation', 'volume': '5', 'author': 'Rose', 'year': '2009', 'journal-title': 'Int. J. Biostat.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0053', 'series-title': 'Encyclopedia of Quantitative Risk Analysis and Assessment', 'article-title': 'Case–control studies', 'author': 'Rothman', 'year': '2008'}, { 'issue': '10359', 'key': '10.1016/j.euroneuro.2023.03.011_bib0054', 'doi-asserted-by': 'crossref', 'first-page': '1224', 'DOI': '10.1016/S0140-6736(22)01585-9', 'article-title': 'The Lancet Commission on lessons for the future from the COVID-19 ' 'pandemic', 'volume': '400', 'author': 'Sachs', 'year': '2022', 'journal-title': 'Lancet'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0055', 'doi-asserted-by': 'crossref', 'first-page': '683', 'DOI': '10.1002/art.27304', 'article-title': 'Fluoxetine and citalopram exhibit potent antiinflammatory activity in ' 'human and murine models of rheumatoid arthritis and inhibit toll-like ' 'receptors', 'volume': '62', 'author': 'Sacre', 'year': '2010', 'journal-title': 'Arthritis Rheum.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0056', 'doi-asserted-by': 'crossref', 'DOI': '10.1136/bmjgh-2021-007031', 'article-title': 'New waves, new variants, old inequity: a continuing COVID-19 crisis', 'volume': '6', 'author': 'Saha', 'year': '2021', 'journal-title': 'BMJ Global Health'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0057', 'doi-asserted-by': 'crossref', 'first-page': 'ofab050', 'DOI': '10.1093/ofid/ofab050', 'article-title': 'Prospective cohort of fluvoxamine for early treatment of coronavirus ' 'disease 19', 'volume': '8', 'author': 'Seftel', 'year': '2021', 'journal-title': 'Open Forum Infect. Dis.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0058', 'doi-asserted-by': 'crossref', 'first-page': '2293', 'DOI': '10.1056/NEJMsb1609216', 'article-title': 'Real-world evidence—what is it and what can it tell us?', 'volume': '375', 'author': 'Sherman', 'year': '2016', 'journal-title': 'N. Engl. J. Med.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0059', 'doi-asserted-by': 'crossref', 'first-page': '385', 'DOI': '10.1016/S0140-6736(21)01642-1', 'article-title': 'Spike-antibody waning after second dose of BNT162b2 or ChAdOx1', 'volume': '398', 'author': 'Shrotri', 'year': '2021', 'journal-title': 'Lancet'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0060', 'doi-asserted-by': 'crossref', 'first-page': '428', 'DOI': '10.1016/S0140-6736(11)60478-9', 'article-title': 'Vaccine production, distribution, access, and uptake', 'volume': '378', 'author': 'Smith', 'year': '2011', 'journal-title': 'Lancet'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0061', 'series-title': 'Generalized Linear Mixed Models: Modern Concepts, Methods and ' 'Applications. 1a', 'author': 'Stroup', 'year': '2021'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0062', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fphar.2021.652688', 'article-title': 'Fluvoxamine: a review of its mechanism of action and its role in ' 'COVID-19', 'volume': '12', 'author': 'Sukhatme', 'year': '2021', 'journal-title': 'Front. Pharmacol.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0063', 'doi-asserted-by': 'crossref', 'first-page': '361', 'DOI': '10.1097/PRA.0000000000000578', 'article-title': 'Selective serotonin reuptake inhibitors: how long is long enough?', 'volume': '27', 'author': 'Thom', 'year': '2021', 'journal-title': 'J. Psychiatr. Pract.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0064', 'doi-asserted-by': 'crossref', 'first-page': 'e1355', 'DOI': '10.1016/S2214-109X(20)30415-0', 'article-title': "COVID-19 vaccination: returning to WHO's health for all", 'volume': '8', 'author': 'Torres', 'year': '2020', 'journal-title': 'Lancet Global Health'}, { 'issue': '3', 'key': '10.1016/j.euroneuro.2023.03.011_bib0065', 'doi-asserted-by': 'crossref', 'first-page': '469', 'DOI': '10.1016/j.bbi.2011.12.011', 'article-title': 'A comparative examination of the anti-inflammatory effects of SSRI and ' 'SNRI antidepressants on LPS stimulated microglia', 'volume': '26', 'author': 'Tynan', 'year': '2012', 'journal-title': 'Brain Behav. Immun.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0066', 'doi-asserted-by': 'crossref', 'first-page': 'e63', 'DOI': '10.1016/S2213-2600(21)00270-8', 'article-title': 'Repurposing drugs for treatment of COVID-19', 'volume': '9', 'author': 'Venkatesan', 'year': '2021', 'journal-title': 'Lancet Respir. Med.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0067', 'doi-asserted-by': 'crossref', 'first-page': '24', 'DOI': '10.1016/j.bbi.2019.02.021', 'article-title': 'Effects of SSRIs on peripheral inflammatory markers in patients with ' 'major depressive disorder: a systematic review and meta-analysis', 'volume': '79', 'author': 'Wang', 'year': '2019', 'journal-title': 'Brain Behav. Immun.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0068', 'article-title': 'Multilevel determinants of COVID-19 vaccination hesitancy in the United ' 'States: a rapid systematic review', 'volume': '25', 'author': 'Wang', 'year': '2021', 'journal-title': 'Prev. Med. Rep.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0069', 'doi-asserted-by': 'crossref', 'first-page': '497', 'DOI': '10.1056/NEJMoa2023184', 'article-title': 'Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial ' 'results', 'volume': '384', 'author': 'Solidarity Trial Consortium', 'year': '2021', 'journal-title': 'N. Engl. J. Med.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0070', 'series-title': 'Therapeutics and COVID-19: Living Guideline', 'year': '2022'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0071', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fimmu.2020.586572', 'article-title': 'Identification of potent and safe antiviral therapeutic candidates ' 'against SARS-CoV-2', 'volume': '11', 'author': 'Xiao', 'year': '2020', 'journal-title': 'Front. Immunol.'}, { 'key': '10.1016/j.euroneuro.2023.03.011_bib0072', 'doi-asserted-by': 'crossref', 'first-page': '5890', 'DOI': '10.1038/s41598-021-85049-0', 'article-title': 'The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in ' 'human lung tissue', 'volume': '11', 'author': 'Zimniak', 'year': '2021', 'journal-title': 'Sci. Rep.'}], 'container-title': 'European Neuropsychopharmacology', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0924977X23000639?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0924977X23000639?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2023, 4, 26]], 'date-time': '2023-04-26T17:11:37Z', 'timestamp': 1682529097000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0924977X23000639'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2023, 6]]}, 'references-count': 72, 'alternative-id': ['S0924977X23000639'], 'URL': 'http://dx.doi.org/10.1016/j.euroneuro.2023.03.011', 'relation': {}, 'ISSN': ['0924-977X'], 'subject': [ 'Pharmacology (medical)', 'Biological Psychiatry', 'Psychiatry and Mental health', 'Neurology (clinical)', 'Neurology', 'Pharmacology'], 'container-title-short': 'European Neuropsychopharmacology', 'published': {'date-parts': [[2023, 6]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: A ' 'population-based study', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'European Neuropsychopharmacology', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.euroneuro.2023.03.011', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2023 The Author(s). Published by Elsevier B.V.', 'name': 'copyright', 'label': 'Copyright'}]}